Immune Therapeutics, Inc. Stock Other OTC
Equities
IMUN
US45252A1079
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.11M 8.41M |
---|---|---|---|---|---|
Net income 2022 | -3M -4.13M | Net income 2023 | -1M -1.38M | EV / Sales 2022 | - |
Net Debt 2022 | 546K 751K | Net Debt 2023 | 1.15M 1.59M | EV / Sales 2023 | - |
P/E ratio 2022 |
-6
x | P/E ratio 2023 |
-3.65
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 31.15% |
Managers | Title | Age | Since |
---|---|---|---|
Noreen Griffin
FOU | Founder | 71 | 93-12-01 |
Glen Farmer
DFI | Director of Finance/CFO | 55 | 22-08-01 |
Robert Wilson
BRD | Director/Board Member | 51 | 22-05-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Wilson
BRD | Director/Board Member | 51 | 22-05-30 |
Mary Caperton
BRD | Director/Board Member | 62 | 23-10-23 |
Roger Suro
BRD | Director/Board Member | 50 | 11-07 |
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |